Carolinas Wealth Consulting’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-388
Closed -$320K 536
2025
Q1
$320K Buy
388
+154
+66% +$128K 0.07% 133
2024
Q4
$180K Sell
234
-34
-13% -$28.2K 0.04% 191
2024
Q3
$237K Sell
268
-52
-16% -$46.8K 0.04% 168
2024
Q2
$289K Buy
320
+40
+14% +$32K 0.06% 146
2024
Q1
$218K Sell
280
-40,996
-99% -$29.2M 0.04% 165
2023
Q4
$261K Buy
41,276
+26
+0.1% +$15.2K 0.06% 133
2023
Q3
$237K Sell
41,250
-257
-0.6% -$132K 0.06% 132
2023
Q2
$327K Sell
41,507
-185
-0.4% -$77.6K 0.06% 131
2023
Q1
$314K Buy
41,692
+13
+0% +$4.38K 0.07% 132
2022
Q4
$327K Buy
41,679
+1
+0% +$355 0.07% 127
2022
Q3
$293K Sell
41,678
-179
-0.4% -$56.7K 0.07% 121
2022
Q2
$352K Buy
41,857
+41,198
+6,252% +$12.4M 0.09% 108
2022
Q1
$189K Sell
659
-4
-0.6% -$1.03K 0.04% 176
2021
Q4
$183K Sell
663
-162
-20% -$41.1K 0.04% 184
2021
Q3
$191K Buy
825
+141
+21% +$34.8K 0.04% 163
2021
Q2
$157K Buy
684
+111
+19% +$22.3K 0.03% 200
2021
Q1
$107K Sell
573
-284
-33% -$55.6K 0.03% 244
2020
Q4
$145K Buy
857
+18
+2% +$2.69K 0.04% 181
2020
Q3
$124K Buy
839
+652
+349% +$101K 0.04% 169
2020
Q2
$31K Buy
+187
New +$28.7K 0.01% 250

Other funds holding LLY

Carolinas Wealth Consulting's LLY Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 388 shares — an estimated $320K sold.

Carolinas Wealth Consulting first reported a position in LLY in Q2 2020 and held it in 20 quarters. The position peaked at $352K in Q2 2022. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 388 Eli Lilly shares in Q2 2025, an estimated $320K.
  • Carolinas Wealth Consulting first reported a position in Eli Lilly in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Eli Lilly position peaked at $352K in Q2 2022.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.